A Study in Advanced Cancer
NCT01226485
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
Taladegib
Sponsor
Eli Lilly and Company